Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agents

Synthesis and Biological Activities of 2-Amino-1-arylidenamino Imidazoles as Orally Active Anticancer Agents

(2010) Wen-Tai Li et al.   JOURNAL OF MEDICINAL CHEMISTRY

Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance

(2009) E. A. Perez   MOLECULAR CANCER THERAPEUTICS

Animal models of chemotherapy-evoked painful peripheral neuropathies

(2009) Nicolas Authier et al.   Neurotherapeutics

Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91

(2009) Teng-Kuang Yeh et al.   PHARMACOLOGICAL RESEARCH

Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug Discovery

(2008) Yue-Zhong Shu et al.   AAPS Journal

New tubulin targeting agents currently in clinical development

(2008) Robert O Carlson   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Neurotoxic effects of antineoplastic drugs: the lesson of pre-clinical studies

(2008) Guido Cavaletti   Frontiers in Bioscience-Landmark

Enhanced oral bioavailability of paclitaxel by d-α-tocopheryl polyethylene glycol 400 succinate in mice

(2008) Pei-Yin Ho et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS